On August 06, 2026, Elanco Animal Health Inc ELAN shares fell 7.7% to $24.20, continuing a challenging week where the stock has declined by 8.5%. Over the past year, ELAN has traded between a low of $13.76 and a high of $27.98. The recent downturn raises questions about its valuation amid fluctuating market sentiments.
- GF Valueâ„¢ verdict: Current price $24.20 vs GF Valueâ„¢ $15.62, indicating 54.9% overvaluation.
- GF Scoreâ„¢: 66/100, suggesting ELAN is above average among its peers.
- Most notable signal: Insider activity shows a purchase of $0.2M in the last 3 months with no selling.
Is ELAN Overvalued or Undervalued?
Elanco Animal Health Inc currently trades significantly higher than its GF Valueâ„¢, which is estimated at $15.62. This represents a substantial overvaluation of 54.9% based on the proprietary methodology of GuruFocus that combines historical trading multiples, past business growth, and future performance estimates. Given that ELAN is unprofitable and cash-flow-negative, relying on earnings-based valuations such as Price-to-Earnings (P/E) may not be appropriate and could skew perceptions of its value. Instead, a Price-to-Sales (P/S) analysis may provide clearer insights, especially since ELAN has historically traded around a median P/S ratio of approximately 2.5x.
The GF Valuation label suggests that the stock is significantly overvalued, and the current price presents a risk for investors who may be considering entry points. With the company not generating profits, the lack of margin of safety further raises concerns about the sustainability of its current valuation amidst broader market dynamics.
How Does ELAN's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | Not available | 20.8x (5-Year Median) |
| Forward P/E | 22.2x | Not available |
Since no trailing P/E ratio is available due to ELAN's unprofitable status, the analysis relies on the forward P/E of 22.2x. Compared to its 5-year median P/E of 20.8x, ELAN appears to be trading above its historical valuation. This upward deviation aligns with the GF Valueâ„¢ verdict, reinforcing the notion that the stock is currently overvalued.
What Does ELAN's GF Scoreâ„¢ Tell Us?
The GF Scoreâ„¢ measures a stock's potential based on various factors including financial health, profitability, growth prospects, and market momentum. With a score of 66/100, ELAN ranks above average, but it is important to note the varying strength of its sub-ranks.
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 66 |
| Financial Strength | 5/10 |
| Profitability | 4/10 |
| Growth | 5/10 |
| Valuation | 3/10 |
| Momentum | 10/10 |
ELAN's strongest area lies in its momentum rank of 10/10, indicating a positive trend in recent price movements, while its weakest area is valuation, ranked at 3/10. This discrepancy highlights the potential risks associated with investing in a stock that may not be fundamentally supported by its current price level.
What Are Gurus and Insiders Doing with ELAN?
Currently, 9 gurus hold positions in ELAN, with 4 increasing their stakes and 7 trimming their positions in recent quarters. This mixed activity suggests a cautious sentiment among institutional investors. In addition, insider activity has been relatively positive, with insiders purchasing $0.2M worth of stock over the last three months, indicating some level of confidence in the company's future prospects.
The recent insider buying, coupled with the mixed guru sentiment, reflects a nuanced view of the stock's potential. While the insider purchases could suggest belief in long-term value, the trimming by several gurus indicates that some believe the current valuation may not be justified.
What This Means for Investors
In summary, Elanco Animal Health Inc appears to be overvalued based on the GF Valueâ„¢ of $15.62 compared to its current price of $24.20. The significant overvaluation, combined with the company's lack of profitability, raises concerns for potential investors. While there is some positive momentum and insider buying, these factors do not negate the fundamental risks associated with the stock's current price. For detailed metrics and ongoing updates, you can visit the Elanco Animal Health Inc ELAN stock page.
Frequently Asked Questions
What is ELAN's GF Scoreâ„¢?
ELAN has a GF Scoreâ„¢ of 66/100, indicating that it ranks above average compared to its peers in terms of growth, profitability, and other metrics.
Is ELAN overvalued or undervalued?
Based on the GF Valueâ„¢ estimate, ELAN is considered overvalued, with its current price significantly exceeding the estimated fair value.
What is ELAN's P/E ratio?
ELAN does not have a trailing P/E ratio due to its unprofitability; however, the forward P/E is 22.2x, which is above its historical median of 20.8x.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
